LEADER 03172oam 2200745I 450 001 9910451439603321 005 20200520144314.0 010 $a1-134-63333-5 010 $a0-429-22896-1 010 $a0-203-28001-6 010 $a1-280-32596-8 010 $a0-203-16544-6 024 7 $a10.4324/9780203165447 035 $a(CKB)1000000000250350 035 $a(EBL)166279 035 $a(OCoLC)70765788 035 $a(SSID)ssj0000279923 035 $a(PQKBManifestationID)11195699 035 $a(PQKBTitleCode)TC0000279923 035 $a(PQKBWorkID)10268606 035 $a(PQKB)10981954 035 $a(MiAaPQ)EBC166279 035 $a(Au-PeEL)EBL166279 035 $a(CaPaEBR)ebr2003851 035 $a(CaONFJC)MIL32596 035 $a(EXLCZ)991000000000250350 100 $a20180331d1999 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 00$aGlobal instability $ethe political economy of world economic governance /$fedited by Jonathan Michie and John Grieve Smith 210 1$aLondon ;$aNew York :$cRoutledge,$d1999. 215 $a1 online resource (285 p.) 225 1 $aContemporary political economy series 300 $aDescription based upon print version of record. 311 $a0-415-20223-X 311 $a0-415-20222-1 320 $aIncludes bibliographical references and index. 327 $aBook Cover; Title; Contents; List of figures and tables; List of contributors; Preface and acknowledgements; Introduction; 'Asian capitalism' and the financial crisis; Rejecting exceptionalism: reinterpreting the Asian financial crises; Stabilizing capital flows to developing countries; International finance and global deflation: there is an alternative; Creating international credit rules and the Multilateral Agreement on Investment: what are the alternatives?; World trade liberalisation: national autonomy and global regulation; What role for the Tobin tax in world economic governance? 327 $aTransnational rules for transnational corporations: what next? Will the real IMF please stand up: what does the Fund do and what should it do?; A world central bank?; A new Bretton Woods: reforming the global financial system; Index 330 $aIn Global Instability, internationally renowned contributors examine the key problems besetting the world economy and outline possible solutions 410 0$aContemporary political economy series. 606 $aInternational finance 606 $aBusiness cycles 606 $aEconomic history$y1990- 606 $aInvestments, Foreign 606 $aCompetition, International 608 $aElectronic books. 615 0$aInternational finance. 615 0$aBusiness cycles. 615 0$aEconomic history 615 0$aInvestments, Foreign. 615 0$aCompetition, International. 676 $a332/.042 701 $aMichie$b Jonathan$0123211 701 $aGrieve Smith$b John$0123210 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910451439603321 996 $aGlobal instability$92254812 997 $aUNINA LEADER 03697oas 2201309 a 450 001 9910985991803321 005 20260203110246.0 011 $a1744-7623 035 $a(DE-599)ZDB2030079-7 035 $a(OCoLC)57377994 035 $a(CONSER) 2005265010 035 $a(CKB)111025286559026 035 $a(DE-599)2030079-7 035 $a(EXLCZ)99111025286559026 100 $a20050106a20019999 sy a 101 0 $aeng 135 $aurunu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aExpert opinion on emerging drugs 210 $aLondon $cAshley Publications$d2001- 300 $aRefereed/Peer-reviewed 300 $a"The Prospect for Improved Medicines." 311 08$a1472-8214 606 $aPharmaceutical industry$xForecasting$vPeriodicals 606 $aPharmaceutical technology$vPeriodicals 606 $aDrugs$xResearch$vPeriodicals 606 $aDrugs$xDesign$vPeriodicals 606 $aResearch$vPeriodicals 606 $aDrug Design$vPeriodicals 606 $aDrug Industry$vPeriodicals 606 $aPharmaceutical Preparations$vPeriodicals 606 $aDrug Design 606 $aDrug Industry 606 $aPharmaceutical Preparations 606 $aResearch 606 $aMe?dicaments$xConception$vPe?riodiques 606 $aMe?dicaments$xRecherche$vGuides, manuels, etc 606 $aMe?dicaments$xConception 606 $aIndustrie pharmaceutique 606 $aMe?dicaments 606 $aRecherche 606 $aresearch (function)$2aat 606 $aDrugs$xDesign$2fast$3(OCoLC)fst00898790 606 $aDrugs$xResearch$2fast$3(OCoLC)fst00898894 606 $aPharmaceutical industry$xForecasting$2fast$3(OCoLC)fst01060145 606 $aPharmaceutical technology$2fast$3(OCoLC)fst01060211 608 $aPeriodical. 608 $aperiodicals.$2aat 608 $ahandbooks.$2aat 608 $aPeriodicals.$2fast 608 $aPeriodicals.$2lcgft 608 $aHandbooks and manuals.$2lcgft 608 $aPe?riodiques.$2rvmgf 608 $aGuides et manuels.$2rvmgf 615 0$aPharmaceutical industry$xForecasting 615 0$aPharmaceutical technology 615 0$aDrugs$xResearch 615 0$aDrugs$xDesign 615 2$aResearch 615 2$aDrug Design 615 2$aDrug Industry 615 2$aPharmaceutical Preparations 615 2$aDrug Design. 615 2$aDrug Industry. 615 2$aPharmaceutical Preparations. 615 2$aResearch. 615 6$aMe?dicaments$xConception 615 6$aMe?dicaments$xRecherche 615 6$aMe?dicaments$xConception. 615 6$aIndustrie pharmaceutique. 615 6$aMe?dicaments. 615 6$aRecherche. 615 7$aresearch (function) 615 7$aDrugs$xDesign. 615 7$aDrugs$xResearch. 615 7$aPharmaceutical industry$xForecasting. 615 7$aPharmaceutical technology. 801 0$bCLU 801 1$bCUS 801 2$bOCLCQ 801 2$bUWW 801 2$bUKMGB 801 2$bOCLCQ 801 2$bOCLCF 801 2$bOCLCO 801 2$bOCLCQ 801 2$bOCLCO 801 2$bOCLCQ 801 2$bUAB 801 2$bLIP 801 2$bOCLCO 801 2$bOCLCQ 801 2$bNLE 801 2$bREB 801 2$bOCLCO 801 2$bDLC 801 2$bOCLCO 801 2$bOCLCA 801 2$bAU@ 801 2$bOCLCO 801 2$bOCLCA 801 2$bVT2 801 2$bCASUM 801 2$bOCLCQ 801 2$bOCLCL 801 2$bU3W 906 $aJOURNAL 912 $a9910985991803321 996 $aExpert opinion on emerging drugs$94328832 997 $aUNINA